Cite
HARVARD Citation
Ylitalo, E. et al. (2020). Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti‐androgens. Prostate. 80 (2), pp. 214-224. [Online].